Comparison of Treatment Initiation with Bisoprolol Vs. Enalapril in Chronic Heart Failure Patients: Rationale and Design of CIBIS-III
- 1 June 2004
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in European Journal of Heart Failure
- Vol. 6 (4) , 493-500
Abstract
Background: Angiotensin-converting-enzyme (ACE) inhibitors and β-blockers are standard therapy for chronic heart failure (CHF). β-blockers are recommended to be initiated after ACE-inhibitors, but this order is not evidence based. The initiation order may be important since many, especially elderly CHF patients cannot tolerate target doses of both. Data suggest that β-blockers may be more important to CHF patients than ACE-inhibitors, especially in early stages of CHF. Aims: To compare the effect on combined death or hospitalisation of initial monotherapy with either bisoprolol or enalapril, followed by combination therapy. Methods: One-thousand CHF patients without ACE-inhibitor, β-blocker or angiotensin-receptor-blocker therapy will be randomised 1:1 to monotherapy with either enalapril or bisoprolol for 6 months, followed by combined therapy for 6–18 months. The primary objective is to show non-inferiority for bisoprolol-first vs. enalapril-first regarding combined death or hospitalisation. If that is shown, superiority for bisoprolol-first will be tested. Conclusions: If the trial shows non-inferiority for bisoprolol-first vs. enalapril-first, the first CHF therapy may be chosen based on individual judgement in each patient. If bisoprolol-first is superior to enalapril-first, a β-blocker should be given prior to an ACE-inhibitor in CHF, and the paradigm of testing CHF compounds against a background of ACE-inhibitor therapy will be challenged.Keywords
This publication has 30 references indexed in Scilit:
- Effect of Carvedilol on the Morbidity of Patients With Severe Chronic Heart FailureCirculation, 2002
- Guidelines for the diagnosis and treatment of chronic heart failureEuropean Heart Journal, 2001
- Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF)The Lancet, 1999
- The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trialThe Lancet, 1999
- Clinical Effects of β-Adrenergic Blockade in Chronic Heart FailureCirculation, 1998
- North of England evidence based development project: guideline for angiotensin converting enzyme inhibitors in primary care management of adults with symptomatic heart failureBMJ, 1998
- β‐adrenoceptor blockers in chronic heart failure—a reviewBritish Journal of Clinical Pharmacology, 1997
- Effect of Beta-Blockade on Mortality in Patients With Heart Failure: A Meta-Analysis of Randomized Clinical TrialsJACC, 1997
- Overview of Randomized Trials of Angiotensin-Converting Enzyme Inhibitors on Mortality and Morbidity in Patients With Heart FailureJAMA, 1995
- Pathophysiology of chronic heart failureThe Lancet, 1992